106 related articles for article (PubMed ID: 3530445)
1. Effect of high-dose cyclophosphamide and total-body irradiation on left ventricular function in adult patients with leukemia undergoing allogeneic bone marrow transplantation.
Baello EB; Ensberg ME; Ferguson DW; Kugler JW; Gingrich RD; Armitage JO; Klassen LW; Kirchner PT; Kerber RE; Marcus ML
Cancer Treat Rep; 1986 Oct; 70(10):1187-93. PubMed ID: 3530445
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM
Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
[TBL] [Abstract][Full Text] [Related]
3. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
[TBL] [Abstract][Full Text] [Related]
5. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
[TBL] [Abstract][Full Text] [Related]
6. Fatal cardiac toxicity in bone marrow transplant patients receiving cytosine arabinoside, cyclophosphamide, and total body irradiation.
Trigg ME; Finlay JL; Bozdech M; Gilbert E
Cancer; 1987 Jan; 59(1):38-42. PubMed ID: 3539307
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of adults with acute myelogenous leukemia in remission given 550 cGy of single-exposure total body irradiation, cyclophosphamide, and unrelated donor bone marrow transplants.
Hallemeier C; Girgis M; Blum W; Brown R; Khoury H; Goodnough LT; Vij R; Devine S; Wehde M; Postma S; Lin HS; Dipersio J; Adkins D
Biol Blood Marrow Transplant; 2004 May; 10(5):310-9. PubMed ID: 15111930
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens.
Woods WG; Ramsay NK; Weisdorf DJ; Haake R; Vallera DA; Kim TH; Lasky L; Nesbit ME; Bostrom B; Uckun F
Bone Marrow Transplant; 1990 Jul; 6(1):9-16. PubMed ID: 2202462
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up of allogeneic bone marrow transplantation for patients with chronic phase chronic myeloid leukemia prepared with a regimen consisting of cyclophosphamide, cytarabine and single-dose total body irradiation conditioning.
Zaretsky Y; Rifkind J; Lockwood G; Tsang R; Kiss T; Hasegawa W; Fyles G; Tejpar I; Loach D; Minden M; Messner H; Lipton JH
Bone Marrow Transplant; 2007 Sep; 40(5):423-30. PubMed ID: 17603516
[TBL] [Abstract][Full Text] [Related]
11. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission.
Inoue T; Ikeda H; Yamazaki H; Tang JT; Song C; Teshima T; Murayama S; Ohtani M; Shibata H; Masaoka T
Strahlenther Onkol; 1993 Apr; 169(4):250-5. PubMed ID: 8488461
[TBL] [Abstract][Full Text] [Related]
12. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF
Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249
[TBL] [Abstract][Full Text] [Related]
13. Effects of bone marrow transplantation on myocardial function in children.
Pihkala J; Saarinen UM; Lundström U; Salmo M; Virkola K; Virtanen K; Siimes MA; Pesonen E
Bone Marrow Transplant; 1994 Feb; 13(2):149-55. PubMed ID: 8205083
[TBL] [Abstract][Full Text] [Related]
14. Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant.
Hertenstein B; Stefanic M; Schmeiser T; Scholz M; Göller V; Clausen M; Bunjes D; Wiesneth M; Novotny J; Kochs M
J Clin Oncol; 1994 May; 12(5):998-1004. PubMed ID: 8164054
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancy.
Petersen FB; Appelbaum FR; Buckner CD; Sanders JE; Clift RA; McGuffin R; Bearman SI; Flournoy N; Thomas ED
Bone Marrow Transplant; 1988 Nov; 3(6):619-24. PubMed ID: 3063329
[TBL] [Abstract][Full Text] [Related]
16. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
[TBL] [Abstract][Full Text] [Related]
17. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL
Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibitors in bone marrow transplant recipients with depressed left ventricular function.
Kakavas PW; Ghalie R; Parrillo JE; Kaizer H; Barron JT
Bone Marrow Transplant; 1995 Jun; 15(6):859-61. PubMed ID: 7581081
[TBL] [Abstract][Full Text] [Related]
19. Cardiac involvement in bone marrow transplantation: serial changes in left ventricular size, mass and performance.
Kupari M; Volin L; Suokas A; Hekali P; Ruutu T
J Intern Med; 1990 Apr; 227(4):259-66. PubMed ID: 2182758
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Mori T; Aisa Y; Kato J; Yamane A; Nakazato T; Shigematsu N; Okamoto S
Am J Hematol; 2012 Apr; 87(4):349-53. PubMed ID: 22290459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
